Repare is a leading precision oncology company enabled by our proprietary synthetic lethality approach to the discovery and development of novel therapeutics.
Montréal, Québec
Joined June 2017
- Tweets201
- Following3
- Followers1.1K
- Likes9
Repare Therapeutics retweeted
.@NasdaqExchange congratulates #NasdaqListed @RepareRx on its license and collaboration deal with @Roche. 🎉
The collaboration allows for the development of camonsertib (RP-3500) with potential to expand development into additional tumors and multiple combination studies.
Repare Therapeutics retweeted
The Broad Institute @CancerDepMap launches academic-industrial consortium to identify new cancer therapy targets. Thanks to our partners @abbvie, @AstraZeneca, @Bayer, @bmsnews, @genentech, @GSK, @h3biomedicine, @JanssenGlobal, @RepareRx, @calico
broadinstitute.org/news/broa…
